Brittany Gentile
University of Georgia
H-index: 27
North America-United States
Top articles of Brittany Gentile
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Patient Preferences and Treatment Satisfaction in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Treated with Crovalimab and Approved C5 Inhibitors in the Phase III … | Blood | Austin Kulasekararaj Fernando Ataulfo Gonzalez Fernandez Phillip Scheinberg Nicole Straetmans Yasutaka Ueda | 2023/11/28 |
S183: PHASE III RANDOMIZED, MULTICENTER, OPEN-LABEL COMMODORE 1 TRIAL: COMPARISON OF CROVALIMAB VS ECULIZUMAB IN COMPLEMENT INHIBITOR-EXPERIENCED PATIENTS WITH PAROXYSMAL … | HemaSphere | Phillip Scheinberg Diego Cle John Edwards Valentina Giai Marek Hus | 2023/8/1 |
S181: THE PHASE III, RANDOMIZED COMMODORE 2 TRIAL: RESULTS FROM A MULTICENTER STUDY OF CROVALIMAB VS ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS NAIVE TO … | HemaSphere | Alexander Röth Guangsheng He Andres Brodsky Chatree Chatree Chai-Adisaksopha Teresita Dumagay | 2023/8/1 |
Patient-Reported Outcomes (PROs) in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Treated with Crovalimab and Eculizumab: Results from the Phase III Randomized … | Blood | Jens Panse Jaroslav Cermak Olena Kyselova Akihiko Gotoh Fahri Sahin | 2023/11/28 |
PCR61 Burden and impacts associated with caring for neovascular age-related macular degeneration and diabetic macular edema patients: a multinational caregiver survey | Value in Health | M Adam N Holekamp T Jackson J Lambert HB Lewis | 2022/7/1 |
P831: PATIENT-REPORTED OUTCOMES IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH CROVALIMAB: RESULTS FROM THE COMPOSER TRIAL | HemaSphere | A Röth J Panse B Gentile M Buri H Patel | 2022/6/1 |
Drivers of and barriers to adherence to neovascular age-related macular degeneration and diabetic macular edema treatment management plans: a multi-national qualitative study | Patient preference and adherence | Audrey Giocanti-Aurégan Alfredo García-Layana Tunde Peto Brittany Gentile Gloria C Chi | 2022/3/3 |
PCR275 Patient Experience With Anti–Vascular Endothelial Growth Factor (VEGF) Therapy in Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME): A … | Value in Health | B Gentile MC Desco Esteban T Jackson L Mastropasqua R Tuli | 2022/12/1 |
Performance of the Comprehensive Assessment Tool for Challenges in Hemophilia (CATCH) 2.0 | Blood | Marquita Decker-Palmer Susan Mathias Hilary Colwell Ross Crosby Brittany Gentile | 2022/11/15 |
PSS12 Understanding the Patient Experience with Anti-VEGF Intravitreal Injections and the Impact on Treatment Maintenance: A Qualitative Interview Study | Value in Health | A Giocanti-Aurégan S Lanar HB Lewis D Latibeaudiere A Williams | 2021/6/1 |
Health‐related quality of life with fixed‐duration venetoclax‐obinutuzumab for previously untreated chronic lymphocytic leukemia: Results from the randomized, phase 3 CLL14 trial | American Journal of Hematology | Othman Al‐Sawaf Brittany Gentile Jacob Devine Can Zhang Kavita Sail | 2021/9 |
Barriers to adherence to age-related macular degeneration and diabetic macular edema management plans: A multi-national qualitative study | Investigative Ophthalmology & Visual Science | Nancy M Holekamp Sally Lanar Jérémy Lambert Michael Acquadro Matthew Miera | 2021/6/21 |
How oncologists perceive the availability and quality of information generated from patient-reported outcomes (PROs) | Journal of Patient Experience | Michael Shea Céline Audibert Mark Stewart Brittany Gentile Diana Merino | 2020/4 |
The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria | Blood, The Journal of the American Society of Hematology | Alexander Röth Jun-ichi Nishimura Zsolt Nagy Julia Gaàl-Weisinger Jens Panse | 2020/3/19 |
Validity and reliability of the Colorado Adult Joint Assessment Scale in adults with moderate‐severe hemophilia A | Journal of Thrombosis and Haemostasis | Sharon M Funk Sylvia Engelen Katy Benjamin Olga Moshkovich Brittany Gentile | 2020/2 |
Co-Authors
